Hydrate inhibitors market
Hydrate Inhibitors Market, By Inhibitor Type (Thermodynamic Inhibitors, Low Dosage Hydrate Inhibitors (LDHI’s), and Hybrid), and By Region (North America, Europe, Asia-pacific, Latin America, and Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
- Dec 2022
- CMI555
- 125 Pages
- Excel & Pdf
- Specialty and Fine Chemicals
Summary
Hydrate inhibitors are chemical substances or devices that are designed to control the formation of hydrates during the process of natural gas production. Natural gas hydrates are ice-like solids that form when natural gas and free water are combined at low temperatures and high pressure. It is formed at a gas or an oil condensate well.
Hydrate inhibitors aid in reducing hydrate plugs and line blockages, which occur due to hydrate formation. Hydrate inhibitors are used where mechanical methods such as insulated flow lines and active heating are not feasible.
Global hydrate inhibitors market was valued at US$ 211.68 Mn in 2021 in terms of revenue, exhibiting a CAGR of 6.26 % during the forecast period (2022 to 2030).
Drivers
Increasing demand for low-dosage hydrate inhibitors in the oil & gas industry: The oil & gas industry is one of the major contributors to the growth of the global economy. Large oil and gas complexes have been built across the globe equipped with a large number of technologies for processes such as drilling, engineering, exploitation of oil and gas production, water, oil and gas fluids processing, and transportation. However, the combination of constituents of crude oil and natural gas can lead to calamitous consequences. For instance, combination of many additives of crude oil or natural gas with water leads to formation of hydrate, which can result in outbreaks or major accidents. Therefore, the prevention of hydrate precipitation at minimum operating costs is of paramount importance for the safety of the oil & gas fields.
Figure 1. Global Hydrate Inhibitors Market Value Share (%), By Region, 2021
Market Restraints
Environmental issues associated with the use of anti-agglomerate (AA) LDHI: Anti-agglomerated (AA) LDHI’s prevent hydrate agglomeration and blockage and formation of small hydrate particles, and are suitable for transient flow regimes and have the advantage of highest degree of subcooling. However, they need a condensate phase and may need downstream treatment. The AA LDHI chemistries negatively impacts downstream separation processes, which results in increasing production. This can create difficulties in maintaining compliance with the produced-water quality standard for discharge into the environment.
Hydrate Inhibitors Market Report Coverage
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2021 | Market Size in 2021: | US$ 211.68 Mn |
| Historical Data for: | 2017-2020 | Estimated Year: | 2022 |
| Forecast Period 2022 to 2030 CAGR: | 6.26 % | Forecast Period: | 2022-2030 |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
Halliburton, Ashland Global Specialty Chemicals Inc., Ecolab Inc., Baker Hughes Inc., Innospec Inc., JSC Gazprom Neftekhim Salavat, BASF SE, Evonik Industries AG, Clariant AG, GasHydrate LLC, and Schlumberger Limited. |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Market Trends
Hydrate inhibitors market is expected to grow rapidly in Asia Pacific during the forecast period (2021-2030). This is attributed to increasing demand of hydrate inhibitors from countries including China, Japan, South Korea, and India. Asia Pacific is heavily reliant on hydrocarbon imports from the Middle East and Africa. According to the Energy Information Administration, India is host to large gas reserves off its east coast. Moreover, China's exploitable shale gas reserves are estimated at 21.8 trillion cubic meters, with proven reserves at 544.1 billion cubic meters.
Figure 2. Global Hydrate Inhibitors Market value Share (%), By Inhibitor Type, 2021
Recent Developments
- In 2022, WBI Energy Inc. inaugurated the North Bakken pipeline expansion project that can transport 250 million cubic feet of natural gas per day from the Bakken production area in North Dakota, with the potential to be increased up to 625 million cubic feet per day
- In 2021, Kinder Morgan Inc. acquired Kinetrex Energy for US$310 million. The acquisition includes two small-scale, domestic LNG production and fueling facilities, and a 50% interest in a landfill-based renewable natural gas (RNG) facility in Indiana.
- In 2020, Chevron acquired Nobel Energy, an independent oil & natural gas production company that has a large natural gas business built in Eastern Mediterranean, and such acquisition will increase Chevron's natural gas production capacity
Competitive Section
Major players operating in the global hydrate inhibitors market include Halliburton, Ashland Global Specialty Chemicals Inc., Ecolab Inc., Baker Hughes Inc., Innospec Inc., JSC Gazprom Neftekhim Salavat, BASF SE, Evonik Industries AG, Clariant AG, GasHydrate LLC, and Schlumberger Limited.
Table of Content
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Inhibitor Type
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- PEST Analysis
- PORTER’s Five Forces Analysis
- Market Opportunities
- Regulatory Scenario
- Key Developments
- Industry Trend
- Market Dynamics
- Global Hydrate Inhibitors Market- Impact of Coronavirus (COVID-19) Pandemic
- Overview
- Factors Affecting Global Hydrate Inhibitors Market– COVID-19
- Impact Analysis
- Global Hydrate Inhibitors Market By Inhibitor Type, 2017-2030 (US$ Billion)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
- Thermodynamic Inhibitors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
- Low Dosage Hydrate Inhibitors (LDHI’s)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
- Hybrid
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
- Introduction
- Global Hydrate Inhibitors Market, By Region, 2017 - 2030(US$ Million)
- Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2017 - 2030
- North America
- Market Share Analysis, By Country, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, By Country, 2017 - 2030
- U.S.
- Country Trends
- Market Size and Forecast, By Inhibitor Type, 2017 - 2030(US$ Million)
- Canada
- Country Trends
- Market Size and Forecast, By Inhibitor Type, 2017 - 2030(US$ Million)
- U.S.
- Europe
- Market Share Analysis, By Country, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, By Country, 2017 - 2030
- U.K.
- Country Trends
- Market Size and Forecast, By Inhibitor Type, 2017 - 2030(US$ Million)
- Germany
- Country Trends
- Market Size and Forecast, By Inhibitor Type, 2017 - 2030(US$ Million)
- France
- Country Trends
- Market Size and Forecast, By Inhibitor Type, 2017 - 2030(US$ Million)
- Italy
- Country Trends
- Market Size and Forecast, By Inhibitor Type, 2017 - 2030(US$ Million)
- Spain
- Country Trends
- Market Size and Forecast, By Inhibitor Type, 2017 - 2030(US$ Million)
- Russia
- Country Trends
- Market Size and Forecast, By Inhibitor Type, 2017 - 2030(US$ Million)
- Rest of Europe
- Country Trends
- Market Size and Forecast, By Inhibitor Type, 2017 - 2030(US$ Million)
- U.K.
- Asia Pacific
- Market Share Analysis, By Country, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, By Country, 2017 - 2030
- China
- Country Trends
- Market Size and Forecast, By Inhibitor Type, 2017 - 2030(US$ Million)
- India
- Country Trends
- Market Size and Forecast, By Inhibitor Type, 2017 - 2030(US$ Million)
- Japan
- Country Trends
- Market Size and Forecast, By Inhibitor Type, 2017 - 2030(US$ Million)
- ASEAN
- Country Trends
- Market Size and Forecast, By Inhibitor Type, 2017 - 2030(US$ Million)
- Australia
- Country Trends
- Market Size and Forecast, By Inhibitor Type, 2017 - 2030(US$ Million)
- South Korea
- Country Trends
- Market Size and Forecast, By Inhibitor Type, 2017 - 2030(US$ Million)
- Rest of Asia Pacific
- Country Trends
- Market Size and Forecast, By Inhibitor Type, 2017 - 2030(US$ Million)
- China
- Latin America
- Market Share Analysis, By Country, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, By Country, 2017 - 2030
- Brazil
- Country Trends
- Market Size and Forecast, By Inhibitor Type, 2017 - 2030(US$ Million)
- Argentina
- Country Trends
- Market Size and Forecast, By Inhibitor Type, 2017 - 2030(US$ Million)
- Mexico
- Country Trends
- Market Size and Forecast, By Inhibitor Type, 2017 - 2030(US$ Million)
- Rest of Latin America
- Country Trends
- Market Size and Forecast, By Inhibitor Type, 2017 - 2030(US$ Million)
- Brazil
- Middle East
- Market Share Analysis, By Country, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, By Country, 2017 - 2030
- GCC
- Country Trends
- Market Size and Forecast, By Inhibitor Type, 2017 - 2030(US$ Million)
- Israel
- Country Trends
- Market Size and Forecast, By Inhibitor Type, 2017 - 2030(US$ Million)
- Rest of Middle East
- Country Trends
- Market Size and Forecast, By Inhibitor Type, 2017 - 2030(US$ Million)
- GCC
- Africa
- Market Share Analysis, By Country, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, By Country, 2017 - 2030
- North Africa
- Country Trends
- Market Size and Forecast, By Inhibitor Type, 2017 - 2030(US$ Million)
- Central Africa
- Country Trends
- Market Size and Forecast, By Inhibitor Type, 2017 - 2030(US$ Million)
- South Africa
- Country Trends
- Market Size and Forecast, By Inhibitor Type, 2017 - 2030(US$ Million)
- North Africa
- Introduction
- Competitive Landscape
- Heat Map Analysis
- Market Share Analysis (3x3 Matrix)
- Company Profiles
- Halliburton
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Ashland Global Specialty Chemicals Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Ecolab Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Baker Hughes Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Innospec Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- JSC Gazprom Neftekhim Salavat
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- BASF SE
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Evonik Industries Ag
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Clariant AG
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- GasHydrate LLC
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Schlumberger Limited
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Halliburton
- Analyst Views
- Section
- References
- Research Methodology
- About Us and Sales Contact
Segmentation
Detailed Segmentation:
- Global Hydrate Inhibitors Market, By Inhibitor Type:
- Thermodynamic Inhibitors
- Methanol
- Mono Ethylene Glycol (MEG)
- Low Dosage Hydrate Inhibitors (LDHI’s)
- Anti-Agglomeration Inhibitors/Surfactants
- Quaternary Ammonium Compounds
- Amides
- Bio-surfactants
- Kinetic Inhibitors
- Polyvinylcaprolactam
- Polyvinylpyrrolidone
- Polyethyloxazoline
- N-methyl-N-vinylacetamide
- Tetra pentyl ammonium bromide
- Butoxy-ethanol
- Emulsifiers
- Hybrid
- Thermodynamic Inhibitors
- Global Hydrate Inhibitors Market, By Geography:
- North America
- U.S.
- By Inhibitor Type:
- Thermodynamic Inhibitors
- Methanol
- Mono Ethylene Glycol (MEG)
- Low Dosage Hydrate Inhibitors (LDHI’s)
- Anti-Agglomeration Inhibitors/Surfactants
- Quaternary Ammonium Compounds
- Amides
- Bio-surfactants
- Kinetic Inhibitors
- Polyvinylcaprolactam
- Polyvinylpyrrolidone
- Polyethyloxazoline
- N-methyl-N-vinylacetamide
- Tetra pentyl ammonium bromide
- Butoxy-ethanol
- Emulsifiers
- Hybrid
- Thermodynamic Inhibitors
- By Inhibitor Type:
- Canada
- By Inhibitor Type:
- Thermodynamic Inhibitors
- Methanol
- Mono Ethylene Glycol (MEG)
- Low Dosage Hydrate Inhibitors (LDHI’s)
- Anti-Agglomeration Inhibitors/Surfactants
- Quaternary Ammonium Compounds
- Amides
- Bio-surfactants
- Kinetic Inhibitors
- Polyvinylcaprolactam
- Polyvinylpyrrolidone
- Polyethyloxazoline
- N-methyl-N-vinylacetamide
- Tetra pentyl ammonium bromide
- Butoxy-ethanol
- Emulsifiers
- Hybrid
- Thermodynamic Inhibitors
- By Inhibitor Type:
- U.S.
- Europe
- U.K.
- By Inhibitor Type:
- Thermodynamic Inhibitors
- Methanol
- Mono Ethylene Glycol (MEG)
- Low Dosage Hydrate Inhibitors (LDHI’s)
- Anti-Agglomeration Inhibitors/Surfactants
- Quaternary Ammonium Compounds
- Amides
- Bio-surfactants
- Kinetic Inhibitors
- Polyvinylcaprolactam
- Polyvinylpyrrolidone
- Polyethyloxazoline
- N-methyl-N-vinylacetamide
- Tetra pentyl ammonium bromide
- Butoxy-ethanol
- Emulsifiers
- Hybrid
- Thermodynamic Inhibitors
- By Inhibitor Type:
- Germany
- By Inhibitor Type:
- Thermodynamic Inhibitors
- Methanol
- Mono Ethylene Glycol (MEG)
- Low Dosage Hydrate Inhibitors (LDHI’s)
- Anti-Agglomeration Inhibitors/Surfactants
- Quaternary Ammonium Compounds
- Amides
- Bio-surfactants
- Kinetic Inhibitors
- Polyvinylcaprolactam
- Polyvinylpyrrolidone
- Polyethyloxazoline
- N-methyl-N-vinylacetamide
- Tetra pentyl ammonium bromide
- Butoxy-ethanol
- Emulsifiers
- Hybrid
- Thermodynamic Inhibitors
- By Inhibitor Type:
- France
- By Inhibitor Type:
- Thermodynamic Inhibitors
- Methanol
- Mono Ethylene Glycol (MEG)
- Low Dosage Hydrate Inhibitors (LDHI’s)
- Anti-Agglomeration Inhibitors/Surfactants
- Quaternary Ammonium Compounds
- Amides
- Bio-surfactants
- Kinetic Inhibitors
- Polyvinylcaprolactam
- Polyvinylpyrrolidone
- Polyethyloxazoline
- N-methyl-N-vinylacetamide
- Tetra pentyl ammonium bromide
- Butoxy-ethanol
- Emulsifiers
- Hybrid
- Thermodynamic Inhibitors
- By Inhibitor Type:
- Italy
- By Inhibitor Type:
- Thermodynamic Inhibitors
- Methanol
- Mono Ethylene Glycol (MEG)
- Low Dosage Hydrate Inhibitors (LDHI’s)
- Anti-Agglomeration Inhibitors/Surfactants
- Quaternary Ammonium Compounds
- Amides
- Bio-surfactants
- Kinetic Inhibitors
- Polyvinylcaprolactam
- Polyvinylpyrrolidone
- Polyethyloxazoline
- N-methyl-N-vinylacetamide
- Tetra pentyl ammonium bromide
- Butoxy-ethanol
- Emulsifiers
- Hybrid
- Thermodynamic Inhibitors
- By Inhibitor Type:
- Spain
- By Inhibitor Type:
- Thermodynamic Inhibitors
- Methanol
- Mono Ethylene Glycol (MEG)
- Low Dosage Hydrate Inhibitors (LDHI’s)
- Anti-Agglomeration Inhibitors/Surfactants
- Quaternary Ammonium Compounds
- Amides
- Bio-surfactants
- Kinetic Inhibitors
- Polyvinylcaprolactam
- Polyvinylpyrrolidone
- Polyethyloxazoline
- N-methyl-N-vinylacetamide
- Tetra pentyl ammonium bromide
- Butoxy-ethanol
- Emulsifiers
- Hybrid
- Thermodynamic Inhibitors
- By Inhibitor Type:
- Russia
- By Inhibitor Type:
- Thermodynamic Inhibitors
- Methanol
- Mono Ethylene Glycol (MEG)
- Low Dosage Hydrate Inhibitors (LDHI’s)
- Anti-Agglomeration Inhibitors/Surfactants
- Quaternary Ammonium Compounds
- Amides
- Bio-surfactants
- Kinetic Inhibitors
- Polyvinylcaprolactam
- Polyvinylpyrrolidone
- Polyethyloxazoline
- N-methyl-N-vinylacetamide
- Tetra pentyl ammonium bromide
- Butoxy-ethanol
- Emulsifiers
- Hybrid
- Thermodynamic Inhibitors
- By Inhibitor Type:
- Rest of Europe
- By Inhibitor Type:
- Thermodynamic Inhibitors
- Methanol
- Mono Ethylene Glycol (MEG)
- Low Dosage Hydrate Inhibitors (LDHI’s)
- Anti-Agglomeration Inhibitors/Surfactants
- Quaternary Ammonium Compounds
- Amides
- Bio-surfactants
- Kinetic Inhibitors
- Polyvinylcaprolactam
- Polyvinylpyrrolidone
- Polyethyloxazoline
- N-methyl-N-vinylacetamide
- Tetra pentyl ammonium bromide
- Butoxy-ethanol
- Emulsifiers
- Hybrid
- Thermodynamic Inhibitors
- By Inhibitor Type:
- U.K.
- Asia Pacific
- China
- By Inhibitor Type:
- Thermodynamic Inhibitors
- Methanol
- Mono Ethylene Glycol (MEG)
- Low Dosage Hydrate Inhibitors (LDHI’s)
- Anti-Agglomeration Inhibitors/Surfactants
- Quaternary Ammonium Compounds
- Amides
- Bio-surfactants
- Kinetic Inhibitors
- Polyvinylcaprolactam
- Polyvinylpyrrolidone
- Polyethyloxazoline
- N-methyl-N-vinylacetamide
- Tetra pentyl ammonium bromide
- Butoxy-ethanol
- Emulsifiers
- Hybrid
- Thermodynamic Inhibitors
- By Inhibitor Type:
- India
- By Inhibitor Type:
- Thermodynamic Inhibitors
- Methanol
- Mono Ethylene Glycol (MEG)
- Low Dosage Hydrate Inhibitors (LDHI’s)
- Anti-Agglomeration Inhibitors/Surfactants
- Quaternary Ammonium Compounds
- Amides
- Bio-surfactants
- Kinetic Inhibitors
- Polyvinylcaprolactam
- Polyvinylpyrrolidone
- Polyethyloxazoline
- N-methyl-N-vinylacetamide
- Tetra pentyl ammonium bromide
- Butoxy-ethanol
- Emulsifiers
- Hybrid
- Thermodynamic Inhibitors
- By Inhibitor Type:
- Japan
- By Inhibitor Type:
- Thermodynamic Inhibitors
- Methanol
- Mono Ethylene Glycol (MEG)
- Low Dosage Hydrate Inhibitors (LDHI’s)
- Anti-Agglomeration Inhibitors/Surfactants
- Quaternary Ammonium Compounds
- Amides
- Bio-surfactants
- Kinetic Inhibitors
- Polyvinylcaprolactam
- Polyvinylpyrrolidone
- Polyethyloxazoline
- N-methyl-N-vinylacetamide
- Tetra pentyl ammonium bromide
- Butoxy-ethanol
- Emulsifiers
- Hybrid
- Thermodynamic Inhibitors
- By Inhibitor Type:
- ASEAN
- By Inhibitor Type:
- Thermodynamic Inhibitors
- Methanol
- Mono Ethylene Glycol (MEG)
- Low Dosage Hydrate Inhibitors (LDHI’s)
- Anti-Agglomeration Inhibitors/Surfactants
- Quaternary Ammonium Compounds
- Amides
- Bio-surfactants
- Kinetic Inhibitors
- Polyvinylcaprolactam
- Polyvinylpyrrolidone
- Polyethyloxazoline
- N-methyl-N-vinylacetamide
- Tetra pentyl ammonium bromide
- Butoxy-ethanol
- Emulsifiers
- Hybrid
- Thermodynamic Inhibitors
- By Inhibitor Type:
- Australia
- By Inhibitor Type:
- Thermodynamic Inhibitors
- Methanol
- Mono Ethylene Glycol (MEG)
- Low Dosage Hydrate Inhibitors (LDHI’s)
- Anti-Agglomeration Inhibitors/Surfactants
- Quaternary Ammonium Compounds
- Amides
- Bio-surfactants
- Kinetic Inhibitors
- Polyvinylcaprolactam
- Polyvinylpyrrolidone
- Polyethyloxazoline
- N-methyl-N-vinylacetamide
- Tetra pentyl ammonium bromide
- Butoxy-ethanol
- Emulsifiers
- Hybrid
- Thermodynamic Inhibitors
- By Inhibitor Type:
- South Korea
- By Inhibitor Type:
- Thermodynamic Inhibitors
- Methanol
- Mono Ethylene Glycol (MEG)
- Low Dosage Hydrate Inhibitors (LDHI’s)
- Anti-Agglomeration Inhibitors/Surfactants
- Quaternary Ammonium Compounds
- Amides
- Bio-surfactants
- Kinetic Inhibitors
- Polyvinylcaprolactam
- Polyvinylpyrrolidone
- Polyethyloxazoline
- N-methyl-N-vinylacetamide
- Tetra pentyl ammonium bromide
- Butoxy-ethanol
- Emulsifiers
- Hybrid
- Thermodynamic Inhibitors
- By Inhibitor Type:
- Rest of Asia Pacific
- By Inhibitor Type:
- Thermodynamic Inhibitors
- Methanol
- Mono Ethylene Glycol (MEG)
- Low Dosage Hydrate Inhibitors (LDHI’s)
- Anti-Agglomeration Inhibitors/Surfactants
- Quaternary Ammonium Compounds
- Amides
- Bio-surfactants
- Kinetic Inhibitors
- Polyvinylcaprolactam
- Polyvinylpyrrolidone
- Polyethyloxazoline
- N-methyl-N-vinylacetamide
- Tetra pentyl ammonium bromide
- Butoxy-ethanol
- Emulsifiers
- Hybrid
- Thermodynamic Inhibitors
- By Inhibitor Type:
- China
- Latin America
- Brazil
- By Inhibitor Type:
- Thermodynamic Inhibitors
- Methanol
- Mono Ethylene Glycol (MEG)
- Low Dosage Hydrate Inhibitors (LDHI’s)
- Anti-Agglomeration Inhibitors/Surfactants
- Quaternary Ammonium Compounds
- Amides
- Bio-surfactants
- Kinetic Inhibitors
- Polyvinylcaprolactam
- Polyvinylpyrrolidone
- Polyethyloxazoline
- N-methyl-N-vinylacetamide
- Tetra pentyl ammonium bromide
- Butoxy-ethanol
- Emulsifiers
- Hybrid
- Thermodynamic Inhibitors
- By Inhibitor Type:
- Argentina
- By Inhibitor Type:
- Thermodynamic Inhibitors
- Methanol
- Mono Ethylene Glycol (MEG)
- Low Dosage Hydrate Inhibitors (LDHI’s)
- Anti-Agglomeration Inhibitors/Surfactants
- Quaternary Ammonium Compounds
- Amides
- Bio-surfactants
- Kinetic Inhibitors
- Polyvinylcaprolactam
- Polyvinylpyrrolidone
- Polyethyloxazoline
- N-methyl-N-vinylacetamide
- Tetra pentyl ammonium bromide
- Butoxy-ethanol
- Emulsifiers
- Hybrid
- Thermodynamic Inhibitors
- By Inhibitor Type:
- Mexico
- By Inhibitor Type:
- Thermodynamic Inhibitors
- Methanol
- Mono Ethylene Glycol (MEG)
- Low Dosage Hydrate Inhibitors (LDHI’s)
- Anti-Agglomeration Inhibitors/Surfactants
- Quaternary Ammonium Compounds
- Amides
- Bio-surfactants
- Kinetic Inhibitors
- Polyvinylcaprolactam
- Polyvinylpyrrolidone
- Polyethyloxazoline
- N-methyl-N-vinylacetamide
- Tetra pentyl ammonium bromide
- Butoxy-ethanol
- Emulsifiers
- Hybrid
- Thermodynamic Inhibitors
- By Inhibitor Type:
- Rest of Latin America
- By Inhibitor Type:
- Thermodynamic Inhibitors
- Methanol
- Mono Ethylene Glycol (MEG)
- Low Dosage Hydrate Inhibitors (LDHI’s)
- Anti-Agglomeration Inhibitors/Surfactants
- Quaternary Ammonium Compounds
- Amides
- Bio-surfactants
- Kinetic Inhibitors
- Polyvinylcaprolactam
- Polyvinylpyrrolidone
- Polyethyloxazoline
- N-methyl-N-vinylacetamide
- Tetra pentyl ammonium bromide
- Butoxy-ethanol
- Emulsifiers
- Hybrid
- Thermodynamic Inhibitors
- By Inhibitor Type:
- Brazil
- Middle East
- GCC
- By Inhibitor Type:
- Thermodynamic Inhibitors
- Methanol
- Mono Ethylene Glycol (MEG)
- Low Dosage Hydrate Inhibitors (LDHI’s)
- Anti-Agglomeration Inhibitors/Surfactants
- Quaternary Ammonium Compounds
- Amides
- Bio-surfactants
- Kinetic Inhibitors
- Polyvinylcaprolactam
- Polyvinylpyrrolidone
- Polyethyloxazoline
- N-methyl-N-vinylacetamide
- Tetra pentyl ammonium bromide
- Butoxy-ethanol
- Emulsifiers
- Hybrid
- Thermodynamic Inhibitors
- By Inhibitor Type:
- Israel
- By Inhibitor Type:
- Thermodynamic Inhibitors
- Methanol
- Mono Ethylene Glycol (MEG)
- Low Dosage Hydrate Inhibitors (LDHI’s)
- Anti-Agglomeration Inhibitors/Surfactants
- Quaternary Ammonium Compounds
- Amides
- Bio-surfactants
- Kinetic Inhibitors
- Polyvinylcaprolactam
- Polyvinylpyrrolidone
- Polyethyloxazoline
- N-methyl-N-vinylacetamide
- Tetra pentyl ammonium bromide
- Butoxy-ethanol
- Emulsifiers
- Hybrid
- Thermodynamic Inhibitors
- By Inhibitor Type:
- Rest of Middle East
- By Inhibitor Type:
- Thermodynamic Inhibitors
- Methanol
- Mono Ethylene Glycol (MEG)
- Low Dosage Hydrate Inhibitors (LDHI’s)
- Anti-Agglomeration Inhibitors/Surfactants
- Quaternary Ammonium Compounds
- Amides
- Bio-surfactants
- Kinetic Inhibitors
- Polyvinylcaprolactam
- Polyvinylpyrrolidone
- Polyethyloxazoline
- N-methyl-N-vinylacetamide
- Tetra pentyl ammonium bromide
- Butoxy-ethanol
- Emulsifiers
- Hybrid
- Thermodynamic Inhibitors
- By Inhibitor Type:
- GCC
- Africa
- North Africa
- By Inhibitor Type:
- Thermodynamic Inhibitors
- Methanol
- Mono Ethylene Glycol (MEG)
- Low Dosage Hydrate Inhibitors (LDHI’s)
- Anti-Agglomeration Inhibitors/Surfactants
- Quaternary Ammonium Compounds
- Amides
- Bio-surfactants
- Kinetic Inhibitors
- Polyvinylcaprolactam
- Polyvinylpyrrolidone
- Polyethyloxazoline
- N-methyl-N-vinylacetamide
- Tetra pentyl ammonium bromide
- Butoxy-ethanol
- Emulsifiers
- Hybrid
- Thermodynamic Inhibitors
- By Inhibitor Type:
- Central Africa
- By Inhibitor Type:
- Thermodynamic Inhibitors
- Methanol
- Mono Ethylene Glycol (MEG)
- Low Dosage Hydrate Inhibitors (LDHI’s)
- Anti-Agglomeration Inhibitors/Surfactants
- Quaternary Ammonium Compounds
- Amides
- Bio-surfactants
- Kinetic Inhibitors
- Polyvinylcaprolactam
- Polyvinylpyrrolidone
- Polyethyloxazoline
- N-methyl-N-vinylacetamide
- Tetra pentyl ammonium bromide
- Butoxy-ethanol
- Emulsifiers
- Hybrid
- Thermodynamic Inhibitors
- By Inhibitor Type:
- South Africa
- By Inhibitor Type:
- Thermodynamic Inhibitors
- Methanol
- Mono Ethylene Glycol (MEG)
- Low Dosage Hydrate Inhibitors (LDHI’s)
- Anti-Agglomeration Inhibitors/Surfactants
- Quaternary Ammonium Compounds
- Amides
- Bio-surfactants
- Kinetic Inhibitors
- Polyvinylcaprolactam
- Polyvinylpyrrolidone
- Polyethyloxazoline
- N-methyl-N-vinylacetamide
- Tetra pentyl ammonium bromide
- Butoxy-ethanol
- Emulsifiers
- Hybrid
- Thermodynamic Inhibitors
- By Inhibitor Type:
- North Africa
- North America
- Frequently Asked Questions -
What was the global hydrate inhibitors market size in 2021?
Global hydrate inhibitors market was valued at around US$ 211.68 Mn in 2021.
What are the major factors that are expected to drive the growth of the market during the forecast period?
The market was valued at US$ 211.68 Mn in 2021 in terms of revenue, exhibiting a CAGR of 6.26 % during the forecast period (2022 to 2030).
What are the trends in the market?
Low-dose hydrate inhibitors, substantially reduce chemical consumption, are environmentally friendly and they are suitable for challenging production conditions such as deep-water pipelines and subsea tiebacks.
What are the key factors hampering growth of the market?
Political instability and the low price of oil are some of the major factors that are expected to hamper the growth of the market over the forecast period
Which are the key players in the market?
Major players operating in the market include Halliburton, Ashland Global Specialty Chemicals Inc., Ecolab Inc., Baker Hughes Inc., Innospec Inc., JSC Gazprom Neftekhim Salavat, BASF SE, Evonik Industries AG, Clariant AG, GasHydrate LLC, and Schlumberger Limited
What is the estimated CAGR for the market?
The market is estimated to grow at around 6.26 % CAGR in the forecast period (2022-2030).